Related Experiment Video
Updated: Jun 19, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Youngest patient with Sydenham's chorea: a case report
Padmasani Venkat Ramanan1, Sarala Premkumar, B Ramnath
1Department of Paediatrics, Sri Ramachandra Medical College & Research Institute, Chennai 600116.
Journal of the Indian Medical Association
|October 9, 2009
Summary
Rheumatic fever, particularly chorea, can affect young children under five. This case report details a favorable treatment outcome for a young boy with rheumatic chorea using penicillin, prednisolone, and sodium valproate.
Area of Science:
- Pediatrics
- Rheumatology
- Neurology
Background:
- Rheumatic fever remains prevalent in India, unlike in developed nations.
- While typically affecting school-aged children (5-15 years), rheumatic fever can occur in younger children.
- Younger children (<5 years) with rheumatic fever are thought to present more often with carditis and arthritis, and less frequently with chorea.
Observation:
- This report presents a case of rheumatic chorea in a 3-year-old boy.
- The child exhibited symptoms characteristic of chorea, a neurological manifestation of rheumatic fever.
Findings:
- The patient received a combination therapy including penicillin, prednisolone, and sodium valproate.
- The treatment regimen resulted in a favorable clinical response.
Implications:
- This case highlights that chorea can occur in very young children with rheumatic fever.
- Effective management strategies involving antibiotics and anti-inflammatory/anticonvulsant medications can lead to positive outcomes.
- Further research into the specific presentation and management of rheumatic fever in pre-school-aged children is warranted.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...